OMEPRAZOLE

OMEPRAZOLE was reported 441658 times

OMEPRAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 396 0.7097
1 IMMUNISATION 247 0.5691
2 PALMOPLANTAR KERATODERMA 391 0.5393
3 HYPERTENSIVE NEPHROPATHY 333 0.3121
4 SEDATION COMPLICATION 565 0.2212
5 ATRIAL TACHYCARDIA 463 0.2203
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 230 0.2166
7 END STAGE RENAL DISEASE 3707 0.2030
8 REBOUND ACID HYPERSECRETION 587 0.1939
9 HYPOMAGNESAEMIA 2620 0.1880
10 NEPHROGENIC ANAEMIA 867 0.1870
11 PRURITUS GENITAL 427 0.1812
12 CHRONIC KIDNEY DISEASE 13585 0.1786
13 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 317 0.1781
14 DIABETIC NEPHROPATHY 380 0.1725
15 CREATININE RENAL CLEARANCE DECREASED 624 0.1558
16 HYPERPARATHYROIDISM SECONDARY 339 0.1352
17 TUBULOINTERSTITIAL NEPHRITIS 2501 0.1333
18 CAROTID ARTERY OCCLUSION 485 0.1328
19 ESSENTIAL HYPERTENSION 242 0.1321
20 TENSION HEADACHE 501 0.1164
21 GASTRIC POLYPS 241 0.1066
22 SLEEP TERROR 413 0.0980
23 RENAL INJURY 2867 0.0964
24 HYPOCALCAEMIA 1777 0.0938
25 NEPHROPATHY 810 0.0867
26 BLOOD CALCIUM DECREASED 962 0.0855
27 PULMONARY PAIN 233 0.0797
28 ACUTE KIDNEY INJURY 12045 0.0786
29 HYPOPNOEA 272 0.0783
30 ORTHOSTATIC HYPOTENSION 1323 0.0759
31 NEUTROPENIC SEPSIS 542 0.0758
32 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 402 0.0738
33 RENAL CYST 580 0.0730
34 HIATUS HERNIA 944 0.0728
35 FACIAL PAIN 617 0.0690
36 BLOOD MAGNESIUM DECREASED 593 0.0686
37 GASTROOESOPHAGEAL REFLUX DISEASE 5386 0.0668
38 HYPONATRAEMIA 3763 0.0667
39 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 670 0.0652
40 ABNORMAL LOSS OF WEIGHT 428 0.0627
41 SUBARACHNOID HAEMORRHAGE 637 0.0625
42 IRON DEFICIENCY ANAEMIA 576 0.0623
43 OESOPHAGITIS 681 0.0623
44 IMPAIRED GASTRIC EMPTYING 840 0.0616
45 BRONCHIECTASIS 399 0.0592
46 HYPERCHLORHYDRIA 345 0.0586
47 GASTRITIS 1536 0.0583
48 RHINITIS 465 0.0576
49 HYPOPHOSPHATAEMIA 422 0.0570
50 VITAMIN B12 DEFICIENCY 231 0.0570
51 VASCULITIS 648 0.0556
52 HYPOKALAEMIA 2550 0.0552
53 RENAL FAILURE 7325 0.0551
54 ABDOMINAL TENDERNESS 273 0.0549
55 SPINAL OSTEOARTHRITIS 471 0.0536
56 ATRIOVENTRICULAR BLOCK FIRST DEGREE 230 0.0530
57 PRE-EXISTING CONDITION IMPROVED 330 0.0528
58 GOITRE 216 0.0527
59 RED CELL DISTRIBUTION WIDTH INCREASED 219 0.0527
60 VITAMIN D DEFICIENCY 510 0.0522
61 GINGIVAL PAIN 416 0.0522
62 UPPER GASTROINTESTINAL HAEMORRHAGE 879 0.0522
63 RALES 303 0.0521
64 CYSTIC FIBROSIS 286 0.0516
65 DRUG INTERACTION 8135 0.0512
66 SEASONAL ALLERGY 722 0.0510
67 TOXIC EPIDERMAL NECROLYSIS 769 0.0506
68 PAROSMIA 379 0.0502
69 VENTRICULAR TACHYCARDIA 816 0.0494
70 DIVERTICULUM INTESTINAL 216 0.0493
71 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 434 0.0490
72 POLYURIA 401 0.0489
73 CLOSTRIDIUM DIFFICILE COLITIS 516 0.0486
74 GASTRITIS EROSIVE 226 0.0484
75 RENAL FAILURE ACUTE 2043 0.0481
76 ELECTROLYTE IMBALANCE 557 0.0479
77 NOCTURIA 579 0.0477
78 HEPATIC ENCEPHALOPATHY 443 0.0474
79 INTERVERTEBRAL DISC DEGENERATION 435 0.0470
80 PRODUCT ADMINISTRATION INTERRUPTED 369 0.0470
81 ODYNOPHAGIA 280 0.0469
82 IMPAIRED QUALITY OF LIFE 672 0.0467
83 NEUTROPHIL COUNT INCREASED 475 0.0463
84 SENSORY LOSS 372 0.0462
85 DIVERTICULUM 326 0.0458
86 INTESTINAL ISCHAEMIA 250 0.0454
87 BLOOD SODIUM DECREASED 854 0.0453
88 SLEEP APNOEA SYNDROME 863 0.0452
89 DIALYSIS 640 0.0451
90 HEPATITIS CHOLESTATIC 267 0.0443
91 MOUTH SWELLING 255 0.0441
92 OSTEOPENIA 668 0.0440
93 LIP SWELLING 1460 0.0438
94 FAECALOMA 240 0.0438
95 COGNITIVE DISORDER 2030 0.0434
96 RENAL TUBULAR NECROSIS 426 0.0434
97 BLOOD UREA INCREASED 726 0.0433
98 INTERNATIONAL NORMALISED RATIO INCREASED 1236 0.0433
99 LOWER GASTROINTESTINAL HAEMORRHAGE 320 0.0432
100 RESTLESS LEGS SYNDROME 785 0.0431
101 MUSCLE TWITCHING 984 0.0426
102 INFUSION SITE SWELLING 268 0.0425
103 HAEMATEMESIS 1077 0.0424
104 LIVER FUNCTION TEST ABNORMAL 1230 0.0423
105 ACUTE RESPIRATORY FAILURE 810 0.0421
106 CARDIAC MURMUR 364 0.0420
107 ATRIAL FLUTTER 335 0.0419
108 HYPERKALAEMIA 1465 0.0417
109 SWOLLEN TONGUE 1301 0.0416
110 BODY HEIGHT DECREASED 444 0.0415
111 PANCREATITIS ACUTE 932 0.0414
112 ORAL CANDIDIASIS 546 0.0414
113 MELAENA 910 0.0413
114 HYDRONEPHROSIS 309 0.0412
115 RECTAL HAEMORRHAGE 1761 0.0409
116 HYPERLIPIDAEMIA 488 0.0408
117 BLOOD POTASSIUM DECREASED 1223 0.0406
118 HAIR DISORDER 335 0.0406
119 TRANSIENT ISCHAEMIC ATTACK 1368 0.0405
120 COLITIS ISCHAEMIC 272 0.0403
121 MUSCULOSKELETAL CHEST PAIN 624 0.0403
122 CHOLECYSTITIS 479 0.0402
123 CHROMATURIA 906 0.0401
124 SEDATION 1051 0.0401
125 LOWER RESPIRATORY TRACT INFECTION 1825 0.0401
126 ANOSMIA 580 0.0400
127 ATELECTASIS 387 0.0400
128 OLIGURIA 248 0.0399
129 BALANCE DISORDER 3447 0.0398
130 TINNITUS 1832 0.0398
131 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2080 0.0398
132 HEPATIC STEATOSIS 741 0.0397
133 SPLENOMEGALY 465 0.0397
134 VITAMIN D DECREASED 339 0.0396
135 DYSPNOEA EXERTIONAL 1493 0.0396
136 DIZZINESS POSTURAL 384 0.0396
137 SUPRAVENTRICULAR TACHYCARDIA 378 0.0394
138 BLOOD ALBUMIN DECREASED 313 0.0394
139 UPPER-AIRWAY COUGH SYNDROME 325 0.0394
140 CHOLECYSTITIS CHRONIC 264 0.0394
141 RESPIRATORY TRACT INFECTION 1027 0.0394
142 DUODENAL ULCER 277 0.0392
143 RENAL PAIN 416 0.0392
144 OSTEOARTHRITIS 1660 0.0391
145 PROTEINURIA 741 0.0389
146 UROSEPSIS 359 0.0389
147 URINE OUTPUT DECREASED 340 0.0389
148 DYSPEPSIA 3824 0.0388
149 HAEMATURIA 1324 0.0386
150 FAECES DISCOLOURED 837 0.0386
151 PLATELET COUNT INCREASED 503 0.0385
152 ATRIOVENTRICULAR BLOCK COMPLETE 258 0.0385
153 HYPERTRANSAMINASAEMIA 268 0.0385
154 HAEMATOCRIT DECREASED 763 0.0384
155 DIPLOPIA 997 0.0383
156 MALNUTRITION 428 0.0382
157 SMALL INTESTINAL OBSTRUCTION 470 0.0381
158 DYSURIA 1402 0.0381
159 CLOSTRIDIUM DIFFICILE INFECTION 830 0.0380
160 PRODUCTIVE COUGH 1815 0.0380
161 BLOOD ALKALINE PHOSPHATASE INCREASED 944 0.0380
162 RENAL IMPAIRMENT 3190 0.0379
163 ORAL PAIN 848 0.0378
164 HAEMODIALYSIS 318 0.0378
165 COVID-19 PNEUMONIA 447 0.0378
166 INCONTINENCE 399 0.0377
167 INFUSION SITE PAIN 486 0.0377
168 BLOOD IRON DECREASED 447 0.0376
169 ROTATOR CUFF SYNDROME 482 0.0375
170 INCREASED TENDENCY TO BRUISE 344 0.0374
171 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 290 0.0373
172 ARTERIOSCLEROSIS CORONARY ARTERY 247 0.0372
173 CIRCULATORY COLLAPSE 633 0.0371
174 BRADYKINESIA 219 0.0371
175 GASTROENTERITIS 540 0.0370
176 DEHYDRATION 4933 0.0369
177 BLADDER DISORDER 367 0.0369
178 CONFUSIONAL STATE 5971 0.0369
179 URINARY TRACT INFECTION 6297 0.0369
180 MOUTH ULCERATION 776 0.0368
181 POLYP 241 0.0368
182 INFUSION SITE ERYTHEMA 310 0.0367
183 GASTRIC ULCER 698 0.0367
184 CHOLELITHIASIS 1204 0.0367
185 SPUTUM DISCOLOURED 348 0.0367
186 LARGE INTESTINE POLYP 254 0.0366
187 PELVIC FRACTURE 284 0.0364
188 OSTEOPOROSIS 1500 0.0364
189 GLOMERULAR FILTRATION RATE DECREASED 448 0.0364
190 CARDIOMEGALY 448 0.0364
191 NERVE COMPRESSION 336 0.0364
192 PSYCHOLOGICAL TRAUMA 314 0.0363
193 HOSPICE CARE 359 0.0363
194 LYMPHOEDEMA 251 0.0363
195 RENAL FAILURE CHRONIC 279 0.0362
196 HAEMOPTYSIS 1011 0.0362
197 URINARY INCONTINENCE 1072 0.0361
198 SEROTONIN SYNDROME 692 0.0360
199 INTERVERTEBRAL DISC PROTRUSION 787 0.0360
200 GASTROINTESTINAL HAEMORRHAGE 3005 0.0359
201 ANAL INCONTINENCE 322 0.0358
202 HYPOPHAGIA 915 0.0358
203 MENISCUS INJURY 220 0.0357
204 CARPAL TUNNEL SYNDROME 501 0.0357
205 DRUG LEVEL INCREASED 592 0.0357
206 DIVERTICULITIS 991 0.0357
207 DROOLING 247 0.0357
208 PARKINSONISM 348 0.0357
209 RIB FRACTURE 733 0.0356
210 ATRIAL FIBRILLATION 3469 0.0356
211 HEPATOMEGALY 350 0.0356
212 PERICARDITIS 598 0.0356
213 GASTROINTESTINAL PAIN 391 0.0355
214 POSTOPERATIVE WOUND INFECTION 240 0.0355
215 SPINAL PAIN 416 0.0355
216 RHABDOMYOLYSIS 1480 0.0355
217 HAEMORRHOIDS 692 0.0354
218 ORAL DISORDER 260 0.0354
219 PYELONEPHRITIS 307 0.0354
220 CONSTIPATION 7726 0.0354
221 FLATULENCE 2008 0.0354
222 ASPIRATION 386 0.0352
223 SPINAL COMPRESSION FRACTURE 291 0.0352
224 GAMMA-GLUTAMYLTRANSFERASE INCREASED 780 0.0352
225 HALLUCINATION 2650 0.0351
226 TROPONIN INCREASED 267 0.0351
227 LEUKOCYTOSIS 635 0.0351
228 PULMONARY HYPERTENSION 729 0.0350
229 FOOT DEFORMITY 387 0.0349
230 ANAEMIA 6644 0.0348
231 MULTIPLE ALLERGIES 273 0.0348
232 GROIN PAIN 305 0.0347
233 URINARY RETENTION 1154 0.0345
234 HAIR COLOUR CHANGES 430 0.0345
235 KIDNEY INFECTION 678 0.0345
236 MICTURITION URGENCY 394 0.0345
237 LETHARGY 1984 0.0345
238 SINUS DISORDER 682 0.0344
239 EXOSTOSIS 314 0.0344
240 ARTERIAL OCCLUSIVE DISEASE 270 0.0343
241 CANDIDA INFECTION 579 0.0343
242 ACIDOSIS 262 0.0342
243 EMPHYSEMA 345 0.0342
244 MITRAL VALVE INCOMPETENCE 387 0.0342
245 ABDOMINAL PAIN UPPER 7036 0.0341
246 HAEMOGLOBIN DECREASED 3509 0.0341
247 ACUTE CORONARY SYNDROME 283 0.0341
248 ELECTROCARDIOGRAM ABNORMAL 268 0.0341
249 MUSCULAR WEAKNESS 3881 0.0341
250 MUSCLE RIGIDITY 407 0.0340
251 BLOOD CREATININE INCREASED 2222 0.0340
252 NEURALGIA 826 0.0339
253 NEPHROLITHIASIS 1556 0.0339
254 MYOPATHY 292 0.0338
255 FACIAL PARALYSIS 288 0.0338
256 HEMIPLEGIA 281 0.0337
257 ELECTROCARDIOGRAM QT PROLONGED 1214 0.0337
258 DRY MOUTH 2737 0.0337
259 IMMUNODEFICIENCY 501 0.0336
260 LEFT VENTRICULAR DYSFUNCTION 225 0.0336
261 ABDOMINAL PAIN 7794 0.0335
262 RASH PAPULAR 750 0.0334
263 PERIPHERAL SWELLING 5146 0.0334
264 HEPATITIS ACUTE 217 0.0334
265 FALL 11112 0.0334
266 ARTERIOSCLEROSIS 314 0.0333
267 ECONOMIC PROBLEM 505 0.0333
268 ANGIOEDEMA 1473 0.0333
269 BLOOD POTASSIUM INCREASED 540 0.0332
270 ULCER 529 0.0332
271 OXYGEN SATURATION DECREASED 1862 0.0331
272 OBESITY 527 0.0330
273 ANURIA 284 0.0330
274 SCIATICA 526 0.0330
275 WHITE BLOOD CELL COUNT INCREASED 1265 0.0329
276 CORONARY ARTERY OCCLUSION 451 0.0329
277 BURSITIS 399 0.0329
278 PSEUDOMONAS INFECTION 282 0.0329
279 HYPOXIA 1158 0.0329
280 CHEST PAIN 6082 0.0328
281 JOINT EFFUSION 226 0.0327
282 DEPRESSED LEVEL OF CONSCIOUSNESS 1296 0.0327
283 RED BLOOD CELL COUNT DECREASED 936 0.0327
284 ACUTE MYOCARDIAL INFARCTION 965 0.0327
285 GASTROINTESTINAL INFECTION 293 0.0327
286 RIGHT VENTRICULAR FAILURE 229 0.0326
287 HALLUCINATION, VISUAL 689 0.0326
288 LIPASE INCREASED 250 0.0326
289 PRESYNCOPE 793 0.0326
290 LIGAMENT SPRAIN 322 0.0325
291 CHOLESTASIS 624 0.0325
292 GOUT 582 0.0324
293 PULMONARY MASS 483 0.0324
294 POLLAKIURIA 1350 0.0323
295 MYOCLONUS 386 0.0323
296 SEPSIS 3609 0.0323
297 CONTUSION 3113 0.0323
298 FIBROMYALGIA 786 0.0323
299 BRONCHITIS 2391 0.0323
300 ASCITES 949 0.0323
301 GALLBLADDER DISORDER 576 0.0322
302 HAEMATOMA 836 0.0322
303 TENDERNESS 336 0.0322
304 MYOSITIS 289 0.0322
305 MOUTH HAEMORRHAGE 236 0.0322
306 DISORIENTATION 1275 0.0321
307 DRY THROAT 327 0.0321
308 PANCYTOPENIA 1798 0.0321
309 DIARRHOEA 20740 0.0321
310 ABNORMAL FAECES 263 0.0321
311 CELLULITIS 1617 0.0321
312 PETECHIAE 334 0.0320
313 ONYCHOCLASIS 220 0.0319
314 NEPHROTIC SYNDROME 219 0.0319
315 SINUS CONGESTION 431 0.0319
316 PHARYNGITIS 395 0.0318
317 MUSCULOSKELETAL DISCOMFORT 548 0.0318
318 PNEUMONIA 10308 0.0318
319 PHARYNGEAL SWELLING 311 0.0318
320 DELIRIUM 1103 0.0317
321 BOWEL MOVEMENT IRREGULARITY 243 0.0317
322 RETCHING 676 0.0317
323 SYNCOPE 3170 0.0316
324 MUSCLE STRAIN 274 0.0316
325 PNEUMONITIS 862 0.0316
326 HYPOALBUMINAEMIA 246 0.0316
327 JAUNDICE 851 0.0316
328 BACK PAIN 7344 0.0316
329 ARTHRITIS 2486 0.0316
330 FLANK PAIN 296 0.0315
331 HYPOTENSION 6333 0.0315
332 CYSTITIS 1005 0.0315
333 COUGH 8848 0.0315
334 COAGULOPATHY 525 0.0315
335 MOTOR DYSFUNCTION 321 0.0315
336 MOBILITY DECREASED 2262 0.0315
337 HAIR TEXTURE ABNORMAL 421 0.0314
338 MUCOSAL INFLAMMATION 824 0.0314
339 PULMONARY THROMBOSIS 343 0.0314
340 NECK PAIN 1757 0.0314
341 HYPOGLYCAEMIA 1524 0.0314
342 SEPTIC SHOCK 1367 0.0314
343 SPINAL DISORDER 297 0.0313
344 DISTURBANCE IN ATTENTION 1691 0.0313
345 OEDEMA PERIPHERAL 3821 0.0313
346 ANGINA PECTORIS 898 0.0313
347 PERIPHERAL COLDNESS 430 0.0313
348 DECUBITUS ULCER 255 0.0313
349 LUNG INFILTRATION 276 0.0312
350 LUNG INFECTION 485 0.0312
351 DECREASED APPETITE 7248 0.0312
352 WRIST FRACTURE 374 0.0312
353 MYOCARDIAL ISCHAEMIA 355 0.0312
354 HAND FRACTURE 221 0.0312
355 EPISTAXIS 2331 0.0311
356 FULL BLOOD COUNT DECREASED 627 0.0311
357 ERUCTATION 602 0.0311
358 HYPERCHOLESTEROLAEMIA 300 0.0310
359 C-REACTIVE PROTEIN INCREASED 1129 0.0310
360 FULL BLOOD COUNT ABNORMAL 328 0.0310
361 MUSCLE DISORDER 251 0.0310
362 COORDINATION ABNORMAL 432 0.0309
363 FEELING DRUNK 230 0.0309
364 SKIN LACERATION 336 0.0309
365 APHONIA 431 0.0308
366 FEEDING DISORDER 625 0.0308
367 HYPOAESTHESIA ORAL 464 0.0308
368 PARAESTHESIA ORAL 444 0.0307
369 FOOT FRACTURE 583 0.0307
370 LOCALISED INFECTION 743 0.0307
371 SPINAL FRACTURE 615 0.0307
372 SKIN ULCER 793 0.0306
373 PULMONARY FIBROSIS 588 0.0306
374 ESCHERICHIA INFECTION 252 0.0306
375 ORAL DISCOMFORT 425 0.0306
376 BONE DISORDER 557 0.0305
377 HEAD DISCOMFORT 541 0.0305
378 THYROID DISORDER 470 0.0305
379 TACHYCARDIA 2704 0.0304
380 EOSINOPHILIA 533 0.0304
381 DYSPHAGIA 2886 0.0304
382 DYSPNOEA 17208 0.0304
383 WHEEZING 1802 0.0304
384 WEIGHT DECREASED 8482 0.0304
385 NIGHT SWEATS 979 0.0304
386 TENDON RUPTURE 375 0.0303
387 CHOKING 592 0.0303
388 PULMONARY CONGESTION 400 0.0303
389 HEPATIC CIRRHOSIS 568 0.0302
390 PNEUMOTHORAX 479 0.0302
391 BLOOD PRESSURE ABNORMAL 599 0.0301
392 OROPHARYNGEAL PAIN 2782 0.0300
393 METABOLIC ACIDOSIS 960 0.0300
394 GASTROENTERITIS VIRAL 542 0.0300
395 DENTAL CARIES 332 0.0300
396 EATING DISORDER 639 0.0300
397 PULMONARY OEDEMA 1343 0.0300
398 DIARRHOEA HAEMORRHAGIC 280 0.0299
399 EAR PAIN 582 0.0299
400 NIGHTMARE 1035 0.0299
401 SKIN INFECTION 335 0.0298
402 LIMB INJURY 810 0.0298
403 DYSPHONIA 1743 0.0298
404 BLOOD BILIRUBIN INCREASED 805 0.0298
405 THROAT IRRITATION 1337 0.0298
406 PLEURAL EFFUSION 1813 0.0298
407 UPPER RESPIRATORY TRACT INFECTION 1374 0.0297
408 RENAL DISORDER 1385 0.0297
409 TASTE DISORDER 603 0.0297
410 VOMITING 13956 0.0297
411 ABDOMINAL DISCOMFORT 4972 0.0296
412 ABDOMINAL DISTENSION 3094 0.0296
413 ASTHENIA 11142 0.0296
414 RESPIRATORY FAILURE 2156 0.0295
415 DERMATITIS CONTACT 337 0.0295
416 AMNESIA 1922 0.0295
417 SINUSITIS 3026 0.0295
418 FEELING COLD 821 0.0295
419 PULMONARY EMBOLISM 2799 0.0294
420 TENDONITIS 456 0.0294
421 TORSADE DE POINTES 231 0.0294
422 BLOOD COUNT ABNORMAL 446 0.0294
423 HEMIPARESIS 498 0.0294
424 PALPITATIONS 3441 0.0294
425 HEART RATE INCREASED 2908 0.0293
426 HYPERBILIRUBINAEMIA 304 0.0293
427 OROPHARYNGEAL DISCOMFORT 265 0.0293
428 HERNIA 567 0.0293
429 DEEP VEIN THROMBOSIS 1905 0.0293
430 EYE INFECTION 331 0.0293
431 APHASIA 882 0.0292
432 ALANINE AMINOTRANSFERASE INCREASED 1793 0.0292
433 HEAD INJURY 924 0.0292
434 FEBRILE NEUTROPENIA 1934 0.0291
435 GASTROINTESTINAL INFLAMMATION 228 0.0291
436 BACK DISORDER 473 0.0291
437 DYSARTHRIA 1095 0.0291
438 HYPERHIDROSIS 3746 0.0290
439 COLITIS 1102 0.0290
440 CHOLECYSTECTOMY 332 0.0290
441 WEIGHT FLUCTUATION 304 0.0290
442 VERTIGO 1767 0.0290
443 FLUID RETENTION 1473 0.0289
444 AGEUSIA 719 0.0288
445 VENTRICULAR EXTRASYSTOLES 299 0.0288
446 CYANOSIS 452 0.0287
447 SUBDURAL HAEMATOMA 411 0.0287
448 PAIN IN EXTREMITY 8456 0.0287
449 BONE PAIN 1680 0.0287
450 CONCUSSION 222 0.0286
451 EYE PAIN 1613 0.0286
452 MULTI-ORGAN FAILURE 494 0.0285
453 NEUROPATHY PERIPHERAL 2717 0.0285
454 SUDDEN DEATH 302 0.0285
455 JOINT DISLOCATION 301 0.0284
456 TOOTH INFECTION 375 0.0284
457 GENERALISED OEDEMA 352 0.0284
458 CATARACT 1690 0.0284
459 PALLOR 772 0.0283
460 SQUAMOUS CELL CARCINOMA 267 0.0283
461 ATAXIA 336 0.0283
462 LYMPHOCYTE COUNT DECREASED 500 0.0283
463 VENTRICULAR FIBRILLATION 314 0.0282
464 MADAROSIS 328 0.0282
465 INTESTINAL OBSTRUCTION 1065 0.0282
466 LIMB DISCOMFORT 874 0.0282
467 MUSCLE SPASMS 5181 0.0282
468 ANKLE FRACTURE 437 0.0282
469 BRADYCARDIA 1497 0.0282
470 BLOOD URINE PRESENT 535 0.0282
471 PNEUMONIA ASPIRATION 703 0.0281
472 RESPIRATORY TRACT CONGESTION 447 0.0281
473 MEMORY IMPAIRMENT 3865 0.0281
474 MYALGIA 4780 0.0281
475 TOOTH FRACTURE 309 0.0280
476 PAIN IN JAW 794 0.0280
477 CHEST DISCOMFORT 2870 0.0280
478 HICCUPS 230 0.0280
479 NERVE INJURY 311 0.0279
480 STAPHYLOCOCCAL INFECTION 920 0.0279
481 HEPATITIS 713 0.0278
482 DIZZINESS 13897 0.0278
483 EYE PRURITUS 936 0.0278
484 KNEE ARTHROPLASTY 586 0.0278
485 RESPIRATORY RATE INCREASED 247 0.0278
486 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1336 0.0278
487 HEART RATE IRREGULAR 628 0.0278
488 POST PROCEDURAL INFECTION 226 0.0278
489 PNEUMONIA BACTERIAL 255 0.0278
490 HYPERSOMNIA 796 0.0277
491 RED BLOOD CELL SEDIMENTATION RATE INCREASED 307 0.0277
492 BLOOD CHOLESTEROL INCREASED 1293 0.0277
493 SALIVARY HYPERSECRETION 277 0.0277
494 THROMBOCYTOPENIA 3095 0.0276
495 IMMUNOSUPPRESSION 244 0.0276
496 PHOTOPHOBIA 520 0.0276
497 MUSCULOSKELETAL PAIN 1448 0.0276
498 SWELLING FACE 1797 0.0276
499 PURPURA 244 0.0275
500 TRICUSPID VALVE INCOMPETENCE 219 0.0275
501 ANHEDONIA 724 0.0275
502 BLISTER 1546 0.0275
503 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 708 0.0275
504 BACTERAEMIA 326 0.0274
505 LACERATION 258 0.0274
506 LOCAL SWELLING 478 0.0274
507 TOOTH ABSCESS 279 0.0274
508 INITIAL INSOMNIA 281 0.0274
509 FURUNCLE 217 0.0274
510 POOR QUALITY SLEEP 589 0.0273
511 INFLUENZA 3051 0.0273
512 NODULE 357 0.0273
513 PLATELET COUNT DECREASED 2910 0.0273
514 HYPERTENSION 5776 0.0272
515 ARTHROPATHY 1515 0.0272
516 BASAL CELL CARCINOMA 425 0.0272
517 GAIT DISTURBANCE 5208 0.0272
518 INTERNAL HAEMORRHAGE 310 0.0271
519 BLOOD CREATINE PHOSPHOKINASE INCREASED 781 0.0271
520 PHOTOSENSITIVITY REACTION 448 0.0271
521 RESPIRATORY SYNCYTIAL VIRUS INFECTION 236 0.0271
522 IRRITABLE BOWEL SYNDROME 581 0.0271
523 EAR DISCOMFORT 278 0.0271
524 ARTHRALGIA 11259 0.0271
525 PYREXIA 9368 0.0270
526 PARAESTHESIA 4254 0.0270
527 OEDEMA 1466 0.0270
528 ISCHAEMIC STROKE 482 0.0270
529 HYPOTHYROIDISM 862 0.0270
530 CYST 335 0.0270
531 DYSSTASIA 787 0.0269
532 FATIGUE 20984 0.0269
533 ERYTHEMA MULTIFORME 251 0.0269
534 INSURANCE ISSUE 411 0.0269
535 TREMOR 4461 0.0268
536 FLUID OVERLOAD 391 0.0268
537 DYSGEUSIA 1994 0.0268
538 BLOOD PRESSURE FLUCTUATION 644 0.0268
539 JOINT INJURY 573 0.0268
540 DEPRESSION 6095 0.0268
541 RHINORRHOEA 1731 0.0268
542 MENTAL STATUS CHANGES 743 0.0267
543 MASS 373 0.0267
544 MIGRAINE 2547 0.0267
545 TOOTH DISORDER 592 0.0266
546 FREQUENT BOWEL MOVEMENTS 719 0.0266
547 TOXIC SKIN ERUPTION 268 0.0266
548 HIP FRACTURE 855 0.0266
549 GINGIVAL BLEEDING 363 0.0266
550 LUPUS-LIKE SYNDROME 241 0.0265
551 UNRESPONSIVE TO STIMULI 685 0.0265
552 CORONARY ARTERY DISEASE 803 0.0265
553 PERICARDIAL EFFUSION 613 0.0265
554 UPPER LIMB FRACTURE 528 0.0265
555 BRONCHOSPASM 378 0.0265
556 INTESTINAL PERFORATION 297 0.0264
557 HAEMATOCHEZIA 1459 0.0264
558 NAUSEA 20910 0.0264
559 SKIN DISCOLOURATION 1214 0.0264
560 INFLAMMATION 1362 0.0264
561 RASH MACULO-PAPULAR 587 0.0264
562 ENCEPHALOPATHY 646 0.0263
563 GASTRIC DISORDER 901 0.0262
564 SLEEP DISORDER 1853 0.0262
565 ARRHYTHMIA 1242 0.0262
566 ILEUS 325 0.0261
567 BLOOD TRIGLYCERIDES INCREASED 462 0.0261
568 HEPATIC FAILURE 787 0.0261
569 HYPERCALCAEMIA 322 0.0261
570 INSOMNIA 6943 0.0260
571 THIRST 465 0.0260
572 CARDIAC FAILURE 2089 0.0260
573 SPINAL OPERATION 320 0.0260
574 MALAISE 11384 0.0259
575 PAIN OF SKIN 698 0.0259
576 HYPOTHERMIA 262 0.0259
577 STOMATITIS 1567 0.0258
578 BACTERIAL INFECTION 482 0.0258
579 SNEEZING 579 0.0258
580 BLOOD PRESSURE INCREASED 3945 0.0258
581 SECRETION DISCHARGE 323 0.0258
582 GASTRIC HAEMORRHAGE 296 0.0257
583 HYPERGLYCAEMIA 937 0.0257
584 ASPARTATE AMINOTRANSFERASE INCREASED 1365 0.0257
585 LUNG DISORDER 1259 0.0257
586 TRANSFUSION 269 0.0256
587 JOINT SWELLING 3099 0.0256
588 BODY TEMPERATURE INCREASED 523 0.0256
589 DEPRESSED MOOD 1354 0.0256
590 PANCREATITIS 1353 0.0256
591 DEVICE RELATED INFECTION 394 0.0256
592 SPEECH DISORDER 1341 0.0256
593 RESPIRATORY DISTRESS 705 0.0255
594 RASH MACULAR 892 0.0255
595 DEMENTIA 713 0.0255
596 EJECTION FRACTION DECREASED 396 0.0255
597 BLOOD PRESSURE DECREASED 1693 0.0255
598 MIDDLE INSOMNIA 475 0.0254
599 BRAIN FOG 398 0.0254
600 SINUS TACHYCARDIA 360 0.0253
601 ANXIETY 7215 0.0253
602 BLOOD PRESSURE SYSTOLIC INCREASED 494 0.0253
603 EAR INFECTION 674 0.0253
604 HEPATOTOXICITY 562 0.0252
605 HOT FLUSH 1902 0.0252
606 POST PROCEDURAL COMPLICATION 484 0.0252
607 PRURITUS GENERALISED 545 0.0252
608 LYMPHADENOPATHY 891 0.0251
609 PHARYNGEAL OEDEMA 387 0.0251
610 SINUS BRADYCARDIA 243 0.0251
611 DYSKINESIA 1021 0.0251
612 RASH PRURITIC 1361 0.0251
613 SENSORY DISTURBANCE 403 0.0251
614 BEDRIDDEN 330 0.0251
615 HELICOBACTER INFECTION 258 0.0251
616 SKIN HAEMORRHAGE 372 0.0251
617 CARDIAC FAILURE CONGESTIVE 2012 0.0250
618 TOOTHACHE 453 0.0250
619 STEVENS-JOHNSON SYNDROME 555 0.0249
620 COVID-19 4374 0.0249
621 NAIL DISORDER 218 0.0249
622 ASTHMA 2814 0.0249
623 CARDIO-RESPIRATORY ARREST 1040 0.0248
624 SOMNOLENCE 5005 0.0248
625 MEDICATION ERROR 1380 0.0248
626 HEADACHE 15565 0.0248
627 AGITATION 1822 0.0248
628 SCHIZOPHRENIA 301 0.0247
629 BLINDNESS 1007 0.0247
630 JOINT STIFFNESS 648 0.0247
631 HYPOAESTHESIA 3692 0.0246
632 GAIT INABILITY 824 0.0246
633 NASAL CONGESTION 1448 0.0246
634 APPENDICITIS 230 0.0246
635 FEMUR FRACTURE 762 0.0246
636 AGRANULOCYTOSIS 457 0.0246
637 VIRAL INFECTION 818 0.0246
638 HAEMORRHAGE INTRACRANIAL 367 0.0245
639 DELUSION 381 0.0245
640 VITREOUS FLOATERS 241 0.0245
641 DIABETES MELLITUS INADEQUATE CONTROL 434 0.0245
642 VISION BLURRED 3341 0.0243
643 THROMBOSIS 1957 0.0243
644 DECREASED IMMUNE RESPONSIVENESS 238 0.0242
645 THROAT TIGHTNESS 656 0.0242
646 HEART RATE DECREASED 851 0.0242
647 GASTROINTESTINAL DISORDER 2171 0.0242
648 RESTLESSNESS 886 0.0242
649 DIABETES MELLITUS 1844 0.0242
650 PARANOIA 417 0.0242
651 COLD SWEAT 426 0.0241
652 MUSCLE ATROPHY 306 0.0241
653 WHITE BLOOD CELL COUNT DECREASED 2616 0.0241
654 TACHYPNOEA 328 0.0241
655 LOSS OF CONSCIOUSNESS 3090 0.0241
656 DERMATITIS ALLERGIC 303 0.0241
657 FEELING HOT 1476 0.0241
658 FUNGAL INFECTION 802 0.0240
659 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 408 0.0240
660 SLUGGISHNESS 245 0.0240
661 HYPERTENSIVE CRISIS 267 0.0240
662 BURNING SENSATION 1683 0.0240
663 OCULAR DISCOMFORT 269 0.0239
664 MALIGNANT MELANOMA 321 0.0239
665 WOUND INFECTION 262 0.0239
666 BLOOD LACTATE DEHYDROGENASE INCREASED 379 0.0239
667 MOVEMENT DISORDER 767 0.0239
668 SKIN LESION 655 0.0239
669 HYPOTONIA 238 0.0238
670 HYPOKINESIA 346 0.0238
671 DRY EYE 1188 0.0238
672 CHILLS 2788 0.0238
673 APATHY 346 0.0237
674 QUALITY OF LIFE DECREASED 317 0.0236
675 MANIA 388 0.0236
676 PAIN 14472 0.0235
677 SWELLING 2199 0.0235
678 CEREBRAL HAEMORRHAGE 841 0.0235
679 BACK INJURY 255 0.0234
680 GLOSSODYNIA 524 0.0234
681 REBOUND EFFECT 264 0.0233
682 ACUTE RESPIRATORY DISTRESS SYNDROME 413 0.0233
683 RESPIRATORY DISORDER 697 0.0233
684 CYTOKINE RELEASE SYNDROME 467 0.0233
685 MACULAR DEGENERATION 278 0.0233
686 NEUROLEPTIC MALIGNANT SYNDROME 276 0.0232
687 PLASMA CELL MYELOMA 907 0.0232
688 IMPAIRED HEALING 763 0.0232
689 NEUTROPHIL COUNT DECREASED 947 0.0232
690 GLAUCOMA 447 0.0232
691 HEPATOCELLULAR INJURY 329 0.0232
692 HERPES ZOSTER 1333 0.0232
693 OSTEOMYELITIS 420 0.0232
694 INTENTIONAL PRODUCT USE ISSUE 2028 0.0231
695 NERVOUSNESS 1208 0.0231
696 FEELING ABNORMAL 5520 0.0230
697 LEUKOPENIA 1152 0.0230
698 MENTAL IMPAIRMENT 558 0.0230
699 OBSTRUCTIVE AIRWAYS DISORDER 256 0.0230
700 DECREASED ACTIVITY 248 0.0230
701 IMMUNE SYSTEM DISORDER 302 0.0229
702 MUSCULOSKELETAL STIFFNESS 2007 0.0229
703 ILLNESS 2360 0.0229
704 POOR VENOUS ACCESS 237 0.0229
705 ACTIVITIES OF DAILY LIVING IMPAIRED 450 0.0227
706 HYPERTHYROIDISM 328 0.0226
707 LACRIMATION INCREASED 684 0.0226
708 TYPE 2 DIABETES MELLITUS 761 0.0226
709 VISUAL IMPAIRMENT 2800 0.0226
710 BREAST PAIN 240 0.0225
711 ABASIA 556 0.0225
712 DEAFNESS 588 0.0225
713 RASH ERYTHEMATOUS 1071 0.0224
714 TRANSAMINASES INCREASED 498 0.0224
715 NEUTROPENIA 3044 0.0224
716 FLUSHING 2275 0.0224
717 PULMONARY ARTERIAL HYPERTENSION 322 0.0222
718 INTENTIONAL PRODUCT MISUSE 1941 0.0221
719 PROSTATIC SPECIFIC ANTIGEN INCREASED 305 0.0221
720 PRURITUS 8496 0.0221
721 INFECTION 3191 0.0220
722 HIP ARTHROPLASTY 337 0.0220
723 ORAL HERPES 429 0.0220
724 ALOPECIA 4310 0.0219
725 SEIZURE 2530 0.0219
726 BLOOD TEST ABNORMAL 307 0.0218
727 JOINT RANGE OF MOTION DECREASED 293 0.0218
728 CONDITION AGGRAVATED 6641 0.0218
729 ADRENAL INSUFFICIENCY 265 0.0218
730 NEPHROPATHY TOXIC 245 0.0218
731 PRODUCT DOSE OMISSION IN ERROR 616 0.0217
732 INTENTIONAL DOSE OMISSION 619 0.0217
733 LOWER LIMB FRACTURE 417 0.0217
734 FEELING JITTERY 413 0.0217
735 LIVER DISORDER 959 0.0216
736 CONJUNCTIVITIS 401 0.0216
737 CARDIOMYOPATHY 319 0.0216
738 EYE DISCHARGE 223 0.0214
739 CARDIAC ARREST 1763 0.0213
740 MULTIPLE ORGAN DYSFUNCTION SYNDROME 604 0.0213
741 DRUG-INDUCED LIVER INJURY 668 0.0213
742 FACE OEDEMA 359 0.0213
743 SKIN FISSURES 416 0.0213
744 HALLUCINATION, AUDITORY 338 0.0213
745 LABORATORY TEST ABNORMAL 627 0.0212
746 PARALYSIS 304 0.0212
747 NASOPHARYNGITIS 3912 0.0212
748 LACTIC ACIDOSIS 687 0.0212
749 PANIC ATTACK 772 0.0212
750 BIPOLAR DISORDER 230 0.0211
751 MUSCULOSKELETAL DISORDER 402 0.0211
752 RASH GENERALISED 546 0.0211
753 SCRATCH 222 0.0210
754 GENERAL PHYSICAL HEALTH DETERIORATION 2422 0.0209
755 MUSCLE TIGHTNESS 339 0.0209
756 ANAPHYLACTIC REACTION 1156 0.0209
757 FISTULA 235 0.0209
758 IMPAIRED WORK ABILITY 444 0.0207
759 WEIGHT INCREASED 4643 0.0207
760 ACUTE HEPATIC FAILURE 283 0.0207
761 SCAR 353 0.0206
762 THINKING ABNORMAL 384 0.0206
763 GENERALISED TONIC-CLONIC SEIZURE 341 0.0206
764 TOOTH EXTRACTION 256 0.0205
765 LYMPHOPENIA 290 0.0205
766 WOUND 573 0.0205
767 LIVER FUNCTION TEST INCREASED 440 0.0205
768 PSYCHOTIC DISORDER 605 0.0205
769 EYE HAEMORRHAGE 273 0.0204
770 BRAIN OEDEMA 257 0.0203
771 THERAPY CESSATION 1040 0.0202
772 CARDIOGENIC SHOCK 290 0.0202
773 ABNORMAL DREAMS 557 0.0202
774 METASTASES TO BONE 331 0.0201
775 EYE SWELLING 750 0.0201
776 SURGERY 1175 0.0200
777 RASH 8734 0.0200
778 INCORRECT PRODUCT ADMINISTRATION DURATION 434 0.0200
779 ABSCESS 319 0.0200
780 SCAB 228 0.0200
781 ERECTILE DYSFUNCTION 512 0.0199
782 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 463 0.0198
783 ABDOMINAL PAIN LOWER 502 0.0198
784 POST PROCEDURAL HAEMORRHAGE 231 0.0198
785 PRODUCT DOSE OMISSION 1288 0.0197
786 DERMATITIS 413 0.0197
787 INTERSTITIAL LUNG DISEASE 951 0.0196
788 METASTASES TO CENTRAL NERVOUS SYSTEM 253 0.0196
789 METASTASES TO LIVER 344 0.0196
790 RHEUMATOID ARTHRITIS 2220 0.0195
791 INFLUENZA LIKE ILLNESS 1604 0.0195
792 MYOCARDITIS 223 0.0194
793 METASTASES TO LUNG 223 0.0193
794 SKIN EXFOLIATION 1626 0.0193
795 SKIN DISORDER 642 0.0192
796 NEOPLASM 221 0.0192
797 ACUTE MYELOID LEUKAEMIA 297 0.0190
798 PSORIATIC ARTHROPATHY 773 0.0190
799 PERITONITIS 394 0.0190
800 ECZEMA 995 0.0190
801 DISCOMFORT 1160 0.0190
802 CEREBROVASCULAR ACCIDENT 3219 0.0190
803 HYPOACUSIS 818 0.0190
804 MYELODYSPLASTIC SYNDROME 274 0.0189
805 SUICIDAL IDEATION 1733 0.0189
806 SYSTEMIC LUPUS ERYTHEMATOSUS 671 0.0189
807 EYE IRRITATION 1086 0.0188
808 ANOREXIA 241 0.0187
809 ANKYLOSING SPONDYLITIS 246 0.0186
810 BLINDNESS UNILATERAL 263 0.0186
811 SKIN CANCER 401 0.0186
812 EYELID OEDEMA 216 0.0186
813 PROCEDURAL PAIN 515 0.0185
814 HEPATIC ENZYME INCREASED 1265 0.0185
815 NEUROTOXICITY 325 0.0185
816 DISEASE PROGRESSION 2189 0.0185
817 DISEASE RECURRENCE 879 0.0185
818 DRY SKIN 2462 0.0184
819 INCREASED APPETITE 352 0.0184
820 BONE MARROW FAILURE 374 0.0184
821 EYE DISORDER 605 0.0184
822 DISSEMINATED INTRAVASCULAR COAGULATION 259 0.0184
823 PSYCHOMOTOR HYPERACTIVITY 305 0.0184
824 POLYNEUROPATHY 220 0.0184
825 PRODUCT SUBSTITUTION ISSUE 1057 0.0183
826 TREATMENT NONCOMPLIANCE 996 0.0182
827 HUNGER 252 0.0181
828 LIVER INJURY 443 0.0180
829 MYOCARDIAL INFARCTION 3145 0.0180
830 PRODUCT TASTE ABNORMAL 244 0.0180
831 ALTERED STATE OF CONSCIOUSNESS 390 0.0180
832 MOOD SWINGS 570 0.0179
833 CYTOMEGALOVIRUS INFECTION 297 0.0179
834 FRACTURE 338 0.0178
835 ROAD TRAFFIC ACCIDENT 747 0.0178
836 CARDIAC DISORDER 1670 0.0178
837 DRUG ERUPTION 316 0.0178
838 ACCIDENTAL OVERDOSE 652 0.0178
839 EMOTIONAL DISORDER 548 0.0178
840 CONTRAINDICATED PRODUCT ADMINISTERED 538 0.0178
841 TOXICITY TO VARIOUS AGENTS 2994 0.0177
842 MENTAL DISORDER 770 0.0177
843 ABNORMAL BEHAVIOUR 699 0.0176
844 HEPATIC FUNCTION ABNORMAL 657 0.0176
845 ERYTHEMA 3616 0.0176
846 FEAR 471 0.0175
847 OSTEONECROSIS OF JAW 432 0.0174
848 COLON CANCER 260 0.0174
849 CRYING 633 0.0174
850 DIABETIC KETOACIDOSIS 418 0.0174
851 PRODUCT DOSE OMISSION ISSUE 5112 0.0174
852 COLITIS ULCERATIVE 775 0.0173
853 THERAPY INTERRUPTED 1239 0.0173
854 INTENTIONAL SELF-INJURY 350 0.0173
855 PRODUCT PRESCRIBING ERROR 412 0.0173
856 THERAPEUTIC RESPONSE UNEXPECTED 776 0.0173
857 INFUSION RELATED REACTION 1139 0.0172
858 URTICARIA 2877 0.0172
859 HAEMORRHAGE 1791 0.0171
860 MYDRIASIS 219 0.0171
861 MULTIPLE FRACTURES 280 0.0170
862 MOOD ALTERED 464 0.0170
863 IRRITABILITY 1021 0.0170
864 PSORIASIS 2215 0.0169
865 DRUG DOSE OMISSION 2788 0.0168
866 HYPERSENSITIVITY 3130 0.0168
867 OCULAR HYPERAEMIA 800 0.0168
868 PRODUCT ADMINISTRATION ERROR 339 0.0168
869 VISUAL ACUITY REDUCED 557 0.0168
870 EPILEPSY 511 0.0167
871 PRODUCT USE COMPLAINT 263 0.0167
872 PRESCRIBED UNDERDOSE 332 0.0166
873 SKIN REACTION 232 0.0165
874 UNEVALUABLE EVENT 1244 0.0164
875 DEVICE OCCLUSION 231 0.0164
876 BONE DENSITY DECREASED 503 0.0160
877 WITHDRAWAL SYNDROME 674 0.0160
878 TOOTH LOSS 332 0.0160
879 BLOOD GLUCOSE INCREASED 3008 0.0159
880 SHOCK 367 0.0159
881 PRESCRIBED OVERDOSE 308 0.0159
882 PRODUCT AVAILABILITY ISSUE 361 0.0158
883 CONVULSION 901 0.0157
884 CENTRAL NERVOUS SYSTEM LESION 216 0.0157
885 PRODUCT PHYSICAL ISSUE 317 0.0157
886 BLOOD GLUCOSE ABNORMAL 289 0.0156
887 AGGRESSION 783 0.0156
888 COMA 745 0.0156
889 NEOPLASM PROGRESSION 544 0.0156
890 ADVERSE DRUG REACTION 1400 0.0156
891 ANGER 527 0.0156
892 THERAPY NON-RESPONDER 698 0.0155
893 OFF LABEL USE 13568 0.0155
894 GLYCOSYLATED HAEMOGLOBIN INCREASED 391 0.0155
895 PELVIC PAIN 281 0.0155
896 PRODUCT USE IN UNAPPROVED INDICATION 3832 0.0154
897 INTENTIONAL DRUG MISUSE 323 0.0154
898 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1089 0.0153
899 DRUG PRESCRIBING ERROR 292 0.0152
900 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2730 0.0151
901 ANAPHYLACTIC SHOCK 388 0.0150
902 BLOOD GLUCOSE DECREASED 714 0.0149
903 PRODUCT USE ISSUE 2792 0.0148
904 INJECTION SITE PRURITUS 989 0.0147
905 DYSTONIA 286 0.0147
906 WRONG TECHNIQUE IN DRUG USAGE PROCESS 534 0.0147
907 CEREBRAL INFARCTION 358 0.0146
908 DRUG INTOLERANCE 1398 0.0145
909 MALIGNANT NEOPLASM PROGRESSION 1479 0.0144
910 DRUG EFFECT INCOMPLETE 523 0.0144
911 DISABILITY 278 0.0140
912 HOSPITALISATION 2126 0.0138
913 DRUG EFFECT DECREASED 743 0.0138
914 RESPIRATORY ARREST 376 0.0136
915 CARDIOVASCULAR DISORDER 346 0.0136
916 INJURY 950 0.0135
917 INJECTION SITE RASH 412 0.0134
918 MULTIPLE SCLEROSIS RELAPSE 914 0.0133
919 INCORRECT DRUG ADMINISTRATION DURATION 375 0.0133
920 LUNG NEOPLASM MALIGNANT 547 0.0133
921 INJECTION SITE BRUISING 1049 0.0131
922 INJECTION SITE MASS 485 0.0131
923 COMPLETED SUICIDE 1076 0.0129
924 EMOTIONAL DISTRESS 1559 0.0129
925 ILL-DEFINED DISORDER 782 0.0129
926 THERAPEUTIC PRODUCT EFFECT DECREASED 576 0.0128
927 INJECTION SITE URTICARIA 315 0.0128
928 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 905 0.0127
929 THERAPEUTIC RESPONSE DECREASED 771 0.0127
930 DRUG INEFFECTIVE 16608 0.0126
931 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 216 0.0126
932 INJECTION SITE PAIN 3841 0.0125
933 NERVOUS SYSTEM DISORDER 390 0.0125
934 INTENTIONAL OVERDOSE 799 0.0124
935 INJECTION SITE ERYTHEMA 1525 0.0123
936 INJECTION SITE SWELLING 933 0.0122
937 NEOPLASM MALIGNANT 810 0.0121
938 SUICIDE ATTEMPT 726 0.0120
939 DRUG ADMINISTRATION ERROR 366 0.0119
940 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 648 0.0118
941 THERAPEUTIC RESPONSE SHORTENED 391 0.0118
942 PRODUCT QUALITY ISSUE 1600 0.0118
943 PRODUCT DISPENSING ERROR 255 0.0117
944 MULTIPLE SCLEROSIS 555 0.0116
945 EXPIRED PRODUCT ADMINISTERED 385 0.0116
946 TARDIVE DYSKINESIA 324 0.0115
947 UNDERDOSE 838 0.0115
948 DEATH 9882 0.0115
949 OSTEONECROSIS 374 0.0114
950 GASTRIC CANCER 286 0.0113
951 PREMATURE BABY 338 0.0112
952 INCORRECT DOSE ADMINISTERED 2547 0.0111
953 INJECTION SITE HAEMORRHAGE 887 0.0111
954 ADVERSE EVENT 1017 0.0110
955 INJECTION SITE REACTION 757 0.0110
956 NEEDLE ISSUE 317 0.0109
957 EXPOSURE DURING PREGNANCY 676 0.0109
958 DEVICE ISSUE 967 0.0108
959 DERMATITIS ATOPIC 560 0.0106
960 EXTRAPYRAMIDAL DISORDER 259 0.0104
961 PRODUCT PRESCRIBING ISSUE 220 0.0101
962 DEVICE MALFUNCTION 683 0.0097
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1948 0.0096
964 FOETAL EXPOSURE DURING PREGNANCY 780 0.0096
965 PANCREATIC CARCINOMA 272 0.0094
966 OVERDOSE 2001 0.0093
967 MATERNAL EXPOSURE DURING PREGNANCY 821 0.0092
968 VAGINAL HAEMORRHAGE 396 0.0091
969 PHARMACEUTICAL PRODUCT COMPLAINT 232 0.0089
970 APPLICATION SITE ERYTHEMA 229 0.0087
971 EXTRA DOSE ADMINISTERED 352 0.0087
972 EXPOSURE VIA SKIN CONTACT 223 0.0086
973 DRUG ABUSE 713 0.0086
974 SKIN BURNING SENSATION 569 0.0079
975 DEVICE DISLOCATION 332 0.0076
976 DRUG WITHDRAWAL SYNDROME 651 0.0074
977 SKIN IRRITATION 339 0.0074
978 INCORRECT ROUTE OF DRUG ADMINISTRATION 262 0.0073
979 ACNE 554 0.0073
980 TREATMENT FAILURE 545 0.0066
981 BREAST CANCER 608 0.0065
982 DEVICE LEAKAGE 271 0.0062
983 NO ADVERSE EVENT 1106 0.0061
984 PRODUCT ADHESION ISSUE 217 0.0061
985 ACCIDENTAL EXPOSURE TO PRODUCT 560 0.0054
986 DEVICE BREAKAGE 219 0.0054
987 PROSTATE CANCER 432 0.0054
988 PRODUCT STORAGE ERROR 459 0.0052
989 RENAL CANCER 239 0.0050
990 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 220 0.0047
991 DRUG DEPENDENCE 613 0.0038
992 DRUG DOSE OMISSION BY DEVICE 230 0.0029